{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:14:35Z","timestamp":1769278475044,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ejphar.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T04:16:42Z","timestamp":1300249002000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells"],"prefix":"10.1016","volume":"659","author":[{"given":"Shigeki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.03.002_bb0005","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1128\/IAI.01373-07","article-title":"In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells","volume":"76","author":"Anderson","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0015","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.4049\/jimmunol.162.10.6233","article-title":"IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo","volume":"162","author":"Dabbagh","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12325-008-0105-2","article-title":"Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation","volume":"25","author":"Dal Negro","year":"2008","journal-title":"Adv. Ther."},{"issue":"Pt 2","key":"10.1016\/j.ejphar.2011.03.002_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3440321","article-title":"Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions","volume":"344","author":"Davies","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0925-4439(98)00010-6","article-title":"Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria","volume":"1406","author":"Dohrman","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a Cftr\u2212\/\u2212 mouse carrying a human CFTR-G542X transgene","volume":"80","author":"Du","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1164\/ajrccm.154.2.8756828","article-title":"Diffuse panbronchiolitis in the United States","volume":"154","author":"Fitzgerald","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.ph.57.030195.003135","article-title":"Epithelial mucin genes","volume":"57","author":"Gendler","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","article-title":"Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance","volume":"28","author":"Ghannam","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0065","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1164\/rccm.200208-855OC","article-title":"Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis","volume":"167","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0075","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2005-05-1982","article-title":"Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells","volume":"107","author":"Hasegawa","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF00702348","article-title":"MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions","volume":"13","author":"Hovenberg","year":"1996","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/AAC.39.1.34","article-title":"Macromolecular mechanisms of sputum inhibition of tobramycin activity","volume":"39","author":"Hunt","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dki179","article-title":"Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis","volume":"56","author":"Husson","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0095","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.48.9.3457-3461.2004","article-title":"Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 cells","volume":"48","author":"Imamura","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/dkn427","article-title":"Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin","volume":"63","author":"Ishimoto","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0105","doi-asserted-by":"crossref","first-page":"L847","DOI":"10.1152\/ajplung.00216.2002","article-title":"Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis","volume":"285","author":"Kaneko","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.coi.2005.02.007","article-title":"Pathogen recognition with Toll-like receptors","volume":"17","author":"Kawai","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1124\/mol.62.5.1112","article-title":"Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells","volume":"62","author":"Kim","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2958.2005.04941.x","article-title":"Mucin\u2013Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance","volume":"59","author":"Landry","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.94.3.967","article-title":"Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease","volume":"94","author":"Li","year":"1997","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI6097","article-title":"Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells","volume":"104","author":"Longphre","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/sur.2006.041","article-title":"Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia","volume":"8","author":"Mohr","year":"2007","journal-title":"Surg. Infect. Larchmt."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/AAC.3.4.469","article-title":"Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans","volume":"3","author":"Naber","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(01)06124-4","article-title":"Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis","volume":"358","author":"Ratjen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0160","first-page":"1420","article-title":"A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis","volume":"127","author":"Scheinberg","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0165","doi-asserted-by":"crossref","first-page":"L134","DOI":"10.1152\/ajplung.2001.280.1.L134","article-title":"IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils","volume":"280","author":"Shim","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35037627","article-title":"Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms","volume":"407","author":"Singh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.03.002_bb0175","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4049\/jimmunol.164.3.1546","article-title":"Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils","volume":"164","author":"Takeyama","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0180","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.96.6.3081","article-title":"Epidermal growth factor system regulates mucin production in airways","volume":"96","author":"Takeyama","year":"1999","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0185","first-page":"L15","article-title":"Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides","volume":"272","author":"Tamaoki","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.41.1.184","article-title":"Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis","volume":"41","author":"Touw","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2011.03.002_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/ajrcmb.24.1.4122","article-title":"Lipopolysaccharide induces mucus cell metaplasia in mouse lung","volume":"24","author":"Yanagihara","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:00:45Z","timestamp":1762142445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0014299911002573"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.03.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}